V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006642 | 280004069 | 1.7 | 64.1 | Palliative (P) | null | 2017-11-10 | IVADo | Y | null | 280023546 | DOXORUBICIN + OLARATUMAB |
| 280006643 | 280004070 | 0 | 82 | Palliative (P) | 2014-01-18 | 2014-01-31 | Capecitabine | 02 | N | 280023555 | PACLITAXEL |
| 280006644 | 280004071 | 1.76 | 58 | Curative (C) | 2017-12-09 | 2017-12-30 | Doxorubicin + Olaratumab | N | N | 280023649 | COMPARE TRIAL |
| 280006645 | 280004071 | 1.85 | 64.3 | Adjuvant (A) | 2015-06-06 | 2015-06-25 | CISPLATIN + VINORELBINE | N | N | 280023649 | FEC |
| 280006646 | 280004072 | 1.64 | 54 | Palliative (P) | 2016-08-05 | 2016-08-21 | VIDE | N | N | 280023758 | CARBOPLATIN + VINORELBINE |
| 280006647 | 280004073 | null | null | Curative (C) | 2016-04-07 | 2016-04-07 | Capecitabine | 02 | Y | 280023786 | COMPARE TRIAL |
| 280006648 | 280004074 | 1.77 | 66.1 | Neo-adjuvant (N) | 2017-05-21 | 2017-06-03 | Ifosfamide + Liposomal Doxorubicin | 02 | Y | 280023798 | CISPLATIN + DOCETAXEL |
| 280006649 | 280004074 | 1.82 | 107 | Palliative (P) | 2017-04-15 | 2017-04-18 | Capecitabine + Oxaliplatin 21day | N | N | 280023798 | DOCETAXEL + GEMCITABINE |
| 280006650 | 280010153 | 1.59 | 78.9 | Palliative (P) | 2015-03-01 | 2015-04-12 | Carboplatin + Pemetrexed | Y | Y | 280023901 | CARBOPLATIN + PEMETREXED |
| 280006651 | 280004075 | 1.64 | 70.5 | Palliative (P) | 2017-04-15 | 2017-04-15 | Ifosfamide | N | N | 280023910 | IRINOTECAN + MDG |
| 280006652 | 280004075 | 1.61 | 42.4 | Curative (C) | 2017-05-01 | 2017-05-04 | Docetaxel + Gemcitabine with GCSF | N | null | 280023910 | IVA |
| 280006653 | 280004075 | 1.73 | 101.9 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-19 | IVA | N | N | 280023910 | EURO-EWING |
| 280006654 | 280004076 | 1.72 | 85 | Neo-adjuvant (N) | 2014-09-28 | 2014-10-13 | CISPLATIN + ETOPOSIDE | Y | N | 280024074 | BCG |
| 280006655 | 280008205 | 1.66 | 86.4 | Palliative (P) | 2018-02-01 | 2018-02-14 | DE-ESCALATE TRIAL | N | N | 280024160 | CAPECITABINE + CARBOPLATIN |
| 280006656 | 280008205 | 1.81 | 0 | Palliative (P) | 2018-03-20 | 2018-04-08 | Capecitabine | N | N | 280024160 | CYCLOPHOSPHAMIDE |
| 280006657 | 280004077 | null | 81.7 | Curative (C) | 2017-10-06 | 2017-10-06 | DE-ESCALATE TRIAL | 2 | N | 280024243 | CISPLATIN + FLUOROURACIL + RT |
| 280006658 | 280004078 | 1.51 | 69 | null | 2014-09-19 | 2014-09-26 | DACTINOMYCIN + CYCLO + VINCRISTINE | Y | N | 280024523 | RMS 2005 TRIAL |
| 280006659 | 280004078 | 1.59 | 100 | Neo-adjuvant (N) | 2016-07-02 | 2016-07-03 | Doxorubicin + Olaratumab | 02 | N | 280024523 | CISPLATIN + DOCETAXEL |
| 280006660 | 280004078 | null | null | Adjuvant (A) | 2015-05-08 | 2015-05-28 | CETUXIMAB + IRINOTECAN | N | N | 280024523 | GEMCARBO |
| 280006661 | 280004079 | 1.68 | 112.2 | Palliative (P) | 2017-08-10 | 2017-10-30 | Cisplatin + Pemetrexed | 02 | N | 280024777 | DOCETAXEL + GEMCITABINE |
| 280006662 | 280004080 | 1.8 | 53.8 | Palliative (P) | 2017-09-14 | 2017-10-02 | CARBO + FLUOROURACIL | 2 | N | 280024898 | TRABECTEDIN |
| 280006663 | 280008207 | 1.82 | 60.6 | Neo-adjuvant (N) | 2017-07-04 | 2017-07-04 | IVADo | N | N | 280024907 | CARBO + FLUOROURACIL |
| 280006664 | 280004081 | 1.73 | 65.6 | Curative (C) | 2017-07-27 | 2017-08-03 | Capecitabine | N | N | 280024945 | GEMCARBO |
| 280006665 | 280004082 | 0 | 85.1 | Palliative (P) | null | 2018-05-11 | CompARE Trial | 02 | null | 280025025 | DOXORUBICIN + OLARATUMAB |
| 280006666 | 280008208 | 1.63 | 88.35 | Adjuvant (A) | 2016-10-23 | 2016-10-30 | Cisplatin + Fluorouracil + RT 5day | Y | null | 280025184 | DE-ESCALATE TRIAL |
| 280006667 | 280008208 | 1.77 | 89.8 | Palliative (P) | 2015-03-03 | 2015-03-04 | Capecitabine + Oxaliplatin 21day | 02 | N | 280025184 | CARBOPLATIN + PEMETREXED |
| 280006668 | 280008208 | 1.75 | 87.6 | Neo-adjuvant (N) | 2000-04-18 | 2014-03-15 | BEP 5 Day | N | N | 280025184 | CARBO + FLUOROURACIL |
| 280006669 | 280008208 | 1.84 | 81 | Neo-adjuvant (N) | 2015-08-18 | 2015-08-18 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280025184 | IVA |
| 280006670 | 280004083 | null | null | null | 2017-07-04 | 2018-01-23 | Capecitabine + Oxaliplatin 14day | N | N | 280025539 | GEMCARBO |
| 280006671 | 280004084 | 1.81 | 78.8 | Not known (9) | 2016-07-23 | 2016-07-23 | Doxorubicin + Olaratumab | 02 | N | 280025547 | CAPE + CARBOPLATIN + CETUXIMAB |
| 280006672 | 280008209 | 1.57 | null | Adjuvant (A) | 2018-05-11 | 2018-05-22 | GEMCITABINE | 02 | N | 280025750 | CVD |
| 280006673 | 280008209 | null | null | Palliative (P) | 2015-10-04 | 2015-10-07 | Carboplatin + Vinorelbine Oral | N | null | 280025750 | PAZOPANIB |
| 280006674 | 280008209 | null | 66.8 | Palliative (P) | 2013-02-26 | 2013-02-28 | CETUXIMAB + CISPLATIN + FU | 2 | N | 280025750 | CARBOPLATIN + PEMETREXED |
| 280006675 | 280008209 | 1.74 | null | null | null | 2015-10-24 | Paclitaxel 7 day | null | null | 280025750 | CVP R |
| 280006676 | 280008209 | 1.61 | 64.3 | null | 2016-12-30 | 2017-01-18 | Capecitabine | N | n | 280025750 | MELPHALAN |
| 280006677 | 280008209 | 1.62 | 61.9 | Palliative (P) | 2018-12-09 | 2018-12-09 | DARS Trial | 02 | N | 280025750 | CVD |
| 280006678 | 280008209 | 1.73 | 100.2 | null | 2015-12-14 | 2015-12-15 | Gemcitabine weekly | 02 | N | 280025750 | PACLITAXEL |
| 280006679 | 280008209 | 1.14 | 100 | Palliative (P) | 2016-10-05 | 2016-10-26 | VAC | null | N | 280025750 | DOXORUBICIN + OLARATUMAB |
| 280006680 | 280008209 | 1.7 | 65.1 | Neo-adjuvant (N) | 2016-07-19 | 2016-07-19 | DE-ESCALATE TRIAL | 02 | N | 280025750 | IMATINIB |
| 280006681 | 280008209 | 1.8 | 97 | Curative (C) | 2017-11-26 | 2017-12-09 | Carboplatin+Fluorouracil 4 or 5 day | Y | Y | 280025750 | CISPLATIN + FLUOROURACIL + RT |
| 280006682 | 280004085 | 1.87 | 86.5 | Curative (C) | 2014-02-23 | 2014-02-23 | Mitomycin Intravesical | 02 | N | 280026596 | VIDE |
| 280006683 | 280008210 | 1.77 | 56 | Adjuvant (A) | 2018-06-15 | 2018-06-29 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | Y | N | 280026659 | VIDE |
| 280006684 | 280008210 | 1.7 | 80 | Curative (C) | 2018-11-12 | 2018-11-14 | FLUOROURACIL + OXALIPLATIN | 2 | Y | 280026659 | VAI |
| 280006685 | 280004086 | 1.76 | 65.6 | Palliative (P) | 2015-04-03 | 2015-04-05 | ECX | 02 | N | 280026785 | CARBO + FLUOROURACIL |
| 280006686 | 280004087 | 1.62 | 73.2 | Palliative (P) | 2013-08-23 | 2013-08-23 | CARBOPLATIN + CETUXIMAB | N | N | 280026853 | DOXORUBICIN + OLARATUMAB |
| 280006687 | 280004088 | 1.64 | 51.5 | Curative (C) | 2017-08-31 | 2017-08-31 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280026899 | CISPLATIN + FLUOROURACIL + RT |
| 280006688 | 280004089 | 1.75 | 64.8 | Curative (C) | null | 2019-01-11 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280026963 | IVA |
| 280006689 | 280004089 | 1.78 | 92 | Neo-adjuvant (N) | 2013-09-21 | 2013-10-16 | VIDE | N | N | 280026963 | CISPLATIN + DOXORUBICIN |
| 280006690 | 280004090 | 1.47 | null | Palliative (P) | 2019-04-08 | 2019-04-20 | Cisplatin + Docetaxel | Y | N | 280027571 | IFOSFAMIDE |
| 280006691 | 280004091 | 1.75 | 68 | Curative (C) | 2015-12-17 | 2015-12-20 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | 280027593 | CISPLATIN + VINORELBINE |